Alpha-Lipoic Acid in Diabetic Peripheral Neuropathy: Addressing the Challenges and Complexities Surrounding a...

Area of Science:

• Biochemistry
• Neurology
• Pharmacology

Background:

• Diabetic peripheral neuropathy (DPN) is a growing global health concern with no definitive cure.
• Current DPN treatments offer symptomatic relief but do not alter disease progression.
• Alpha-lipoic acid (ALA), a potent endogenous antioxidant, has been investigated for DPN for decades.

Purpose of the Study:

• To review the historical use and current challenges of ALA in treating DPN.
• To evaluate the existing evidence and identify gaps in ALA's application for DPN management.
• To underscore the need for a comprehensive understanding of ALA therapy parameters in DPN.

Main Methods:

• Comprehensive literature review of nonclinical and clinical studies on ALA and DPN.
• Analysis of ALA's role as a universal antioxidant in cellular function.
• Evaluation of past achievements and current limitations in ALA's therapeutic application for DPN.

Main Results:

• ALA possesses pleiotropic effects beneficial for cellular health.
• Despite extensive research, optimal therapeutic strategies for ALA in DPN remain undefined.
• The complex pathophysiology of DPN presents challenges for targeted therapies like ALA.

Conclusions:

• ALA remains a significant therapeutic candidate for DPN due to its antioxidant properties.
• Further research is crucial to establish optimal protocols for ALA initiation, dosage, duration, and patient monitoring in DPN.
• A deeper understanding of ALA's mechanisms and clinical application is necessary to improve DPN management.